Keros Therapeutics, Inc. short interest in 2026
In 2026, Keros Therapeutics, Inc.'s disclosed short interest ran from 7.70% of shares outstanding on 15 Jan 2026 to 6.77% on 15 Sep 2026, a change of -0.93 percentage points. The year's high was 10.30% on 27 Feb 2026 and its low 4.97% on 31 Jul 2026, averaging 7.22% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.13 days on 15 Sep 2026. Full history: Keros Therapeutics, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 7.70% (15 Jan 2026)
- End of year
- 6.77% (15 Sep 2026)
- Change
- -0.93 pp
- High
- 10.30% (27 Feb 2026)
- Low
- 4.97% (31 Jul 2026)
- Average
- 7.22%
- Highest days to cover
- 9.13 (15 Sep 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 7.70% | 5.25 | |
| 30 Jan 2026 | 7.47% | 8.84 | |
| 13 Feb 2026 | 7.82% | 8.82 | |
| 27 Feb 2026 | 10.30% | 6.60 | |
| 13 Mar 2026 | 10.09% | 3.52 | 10-K filed, results (8-K) |
| 31 Mar 2026 | 7.58% | 2.63 | |
| 15 Apr 2026 | 7.10% | 3.47 | |
| 30 Apr 2026 | 7.18% | 5.36 | |
| 15 May 2026 | 8.64% | 4.65 | 10-Q filed, results (8-K) |
| 29 May 2026 | 7.65% | 4.54 | |
| 15 Jun 2026 | 7.14% | 6.60 | |
| 30 Jun 2026 | 5.21% | 2.54 | |
| 15 Jul 2026 | 5.37% | 4.08 | |
| 31 Jul 2026 | 4.97% | 5.92 | |
| 14 Aug 2026 | 5.79% | 4.73 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 5.88% | 6.09 | |
| 15 Sep 2026 | 6.77% | 9.13 |
See also: Keros Therapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.